Example: Heart Attack

Search clinical trials for: Dalteparin

Total 491 results

NCT03297359

Recruiting

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Conditions: Cancer; Venous Thromboembolism; Obesity
NCT00966277

Completed

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Conditions: Pancreatic Cancer; Venous Thromboembolism
NCT01245998

Completed

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

Conditions: Superficial Thrombophlebitis
NCT00876915

Terminated

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Conditions: Venous Thromboembolism; Pulmonary Embolism
NCT02334007

Completed

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

Conditions: Venous Thromboembolism; Lung Neoplasms; Pulmonary Embolism
NCT01714297

Completed

Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)

Conditions: Arthritis of the Hip; Transfusion Related Complications; Infection; Wound Discharge
NCT00967382

Completed

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study

Conditions: Pregnancy; Thrombophilia; Pregnancy Complications
NCT02607111

Completed

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

Conditions: Kidney Failure
NCT01274637

Completed

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot

Conditions: Venous Thromboembolism; Postpartum
NCT00480636

Completed

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Conditions: Acute Deep Vein Thrombosis
NCT00922766

Completed

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

Conditions: Acute Coronary Syndrome
NCT00765063

Completed

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Conditions: Diabetic Foot Ulcer
NCT00260988

Completed

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Conditions: Thromboembolism; Hemodialysis
NCT01879618

Completed

Use Of Fragmin In Hemodialysis

Conditions: Chronic Renal Failure
NCT01050153

Completed

The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma

Conditions: Venous Thromboembolism
NCT03311984

Unknown status

Anti-Xa Levels in Critically Ill Patients Receiving Low-molecular-weight Heparin for Thromboprophylaxis in China

Conditions: Critically Ill; Anti-Xa
NCT00239980

Completed

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Conditions: Ovarian Cancer
NCT03139487

Recruiting

A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Conditions: Cancer-associated Thrombosis; Esophageal Cancer; Stomach Cancer; Hepatocellular Carcinoma; Pancreatic Cancer; Duodenal Cancer; Esophagogastric Junction Cancer; Malignant Gastrointestinal Stromal Tumor; Ampulla of Vater Cancer; Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)
NCT00942968

Completed

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Conditions: Cancer
NCT00525057

Completed

Dalteparin in Preventing DVT in Participants With Cancer

Conditions: Bone Sarcoma; Femur Fracture; Lymphoma; Metastatic Neoplasm; Pathologic Fracture; Plasma Cell Myeloma; Soft Tissue Sarcoma
NCT00952380

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Conditions: Venous Thromboembolism
NCT00041782

Terminated

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Conditions: Neoplasms; Deep Vein Thrombosis
NCT00432796

Active, not recruiting

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Conditions: Stroke
NCT03593291

Unknown status

LMWH-VTE Prophylaxis for Survivors of Acute Ischemic Stroke- Assessment of Standard Dosing Regimen

Conditions: Stroke
NCT01419977

Completed

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Conditions: Sickle Cell Disease; Vaso-occlusive Crisis